Atlas Trials

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Clinical trial NCT06178926 · UNKNOWN

Trial details

NCT number
NCT06178926
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver CancerCiprofol
Start date
2023-08-01
Primary completion
2024-12-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.